指南制定原则1. 本指南为循证临床实践指南, 是按照循证医学(evidence-based medicine, EBM)
的研究方法制定出的一组临床指导意见, 尊重循证医学依据, 以保证指南更具科学性和权威性. 2 …

Abstract Introduction/Aims Prognostic factors in Duchenne muscular dystrophy (DMD)
predict the disease course and may help individualize patient care. The aim was to …

Skeletal muscle has a tremendous ability to regenerate, attributed to a well-defined
population of muscle stem cells called satellite cells. However, this ability to regenerate …

Sarcolipin (SLN) is an inhibitor of the sarco/endoplasmic reticulum (SR) Ca2+ ATPase
(SERCA) and is abnormally elevated in the muscle of Duchenne muscular dystrophy (DMD) …

Despite the recent progress in the broad‐scaled analysis of proteins in body fluids, there is
still a lack in protein profiling approaches for biomarkers of rare diseases. Scarcity of …

Abnormal intracellular Ca 2+ handling is an important factor in the progressive functional
decline of dystrophic muscle. In the present study, we investigated the function of sarco …

Duchenne muscular dystrophy (DMD) is a common and relentlessly progressive muscle
disease. Some interventions have been identified that modestly slow progression and …

Children with neuromuscular diseases present a wide range of clinical manifestations and
clinical implications for the anaesthesiologist. Neuromuscular diseases in children affect …

Purpose To measure the microstructural changes during skeletal muscle growth and
progressive pathologies using the random permeable model with diffusion MRI, and …

La Distrofia Muscular de Duchenne (DMD) es una enfermedad hereditaria de tipo
neuromuscular progresiva, que se presenta durante la infancia; afecta aproximadamente 1 …